Edition:
United Kingdom

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

57.05USD
22 Jun 2018
Change (% chg)

$-1.30 (-2.23%)
Prev Close
$58.35
Open
$58.15
Day's High
$58.30
Day's Low
$55.65
Volume
518,502
Avg. Vol
205,657
52-wk High
$61.10
52-wk Low
$33.45

Latest Key Developments (Source: Significant Developments)

Supernus announces third quarter 2017 financial results
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Supernus Pharmaceuticals Inc :Supernus announces third quarter 2017 financial results.Q3 earnings per share $0.29.Q3 earnings per share view $0.27 -- Thomson Reuters I/B/E/S.Sees full year 2017 net product sales guidance range to $290 million to $295 million​.Sees ‍FY 2017 operating income in range of $85 million to $90 million​.  Full Article

Supernus pharmaceuticals Inc says FY 2016 net product sales will remain in range of $200 mln- $210 mln
Tuesday, 2 Aug 2016 

Supernus Pharmaceuticals Inc : Supernus announces second quarter 2016 financial results . Q2 revenue $50.4 million versus I/B/E/S view $49.7 million . Q2 earnings per share $0.18 . Q2 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Sees 2016 operating income in range of $32 million to $37 million . For full year 2016, company is reiterating guidance for net product sales .Supernus pharmaceuticals inc says fy 2016 net product sales will remain in range of $200 million to $210 million.  Full Article

BRIEF-Supernus Pharma Reports Q1 Earnings Per Share $0.49

* SUPERNUS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECORD QUARTERLY REVENUE